Sildenafil citrate may offer a potential therapeutic strategy to improve uteroplacental blood flow in FGR pregnancies. FETAL GROWTH RESTRICTION (FGR), when the fetus fails to attain its growth potential, affects approximately 8% of all pregnancies contributing to infant prematurity
The maternal tolerance was analyzed by Dunn et al, and its results are similar to ours, considering that there was no severe adverse maternal side effects by the use of sildenafil in pregnancy and the available evidence suggests that it is a safe medication supported by its potential as therapy for selected maternal
For living healthy sexual life
Sildenafil:
Fildena 100Cenforce 100